Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 1.00 |
| ▸ | MMP2 | P08253 | 3/20 | 0.44 |
| ▸ | ANPEP | P15144 | 3/20 | 0.44 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.39 |
| ▸ | MME | P08473 | 1/20 | 0.39 |
| ▸ | ACE | P12821 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | VHL | P40337 | 2/20 | 0.37 |
| ▸ | DPP4 | P27487 | 2/20 | 0.35 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.35 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxaceprol SCHEMBL4252591 | 1.00 | ATM (1.00) | ATMMMP2ANPEPPIK3CDMME | |
| Oxaceprol SCHEMBL3799956 | 1.00 | ATM (1.00) | ATMMMP2ANPEPPIK3CDMME | |
| Oxaceprol SCHEMBL1285600 | 1.00 | ATM (1.00) | ATMMMP2ANPEPPIK3CDMME | |
| Oxaceprol SCHEMBL5207289 | 1.00 | ATM (1.00) | ATMMMP2ANPEPPIK3CDMME | |
| Oxaceprol SCHEMBL25978 | 1.00 | ATM (1.00) | ATMMMP2ANPEPPIK3CDMME | |
| Oxaceprol SCHEMBL3780150 | 1.00 | ATM (1.00) | ATMMMP2ANPEPPIK3CDMME | |
| Oxaceprol SCHEMBL25977 | 1.00 | ATM (1.00) | ATMMMP2ANPEPPIK3CDMME | |
| Oxaceprol SCHEMBL11772248 | 0.98 | ATM (0.96) | ATMMMP2ANPEPPIK3CDMME | |
| SCHEMBL4432465 | 0.93 | ATM (0.86) | ATMMMP2ANPEPPIK3CDMME | |
| SCHEMBL4432472 | 0.93 | ATM (0.86) | ATMMMP2ANPEPPIK3CDMME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7988 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026087103-A1 | COMBINATION OF RETINOL, ALKYLAMIDOTHIAZOLES AND FLAVONOIDS FOR IMPROVING ACTIVE SUBSTANCE STABILIZATION | BEIERSDORF AG (DE) | 2026-04-30 | — | — | WO | claimed |
| EP-4701615-A1 | RETINOL-CONTAINING COSMETIC PREPARATION HAVING GOOD STABILITY AND SKIN COMPATIBILITY | Beiersdorf AG (DE) | 2026-03-04 | — | — | EP | claimed |
| EP-4701742-A1 | RETINOL-CONTAINING COSMETIC PREPARATION WITH GOOD SKIN COMPATIBILITY | Beiersdorf AG (DE) | 2026-03-04 | — | — | EP | claimed |
| EP-4701743-A1 | RETINOL-CONTAINING COSMETIC PREPARATION WITH GOOD STABILITY, SKIN COMPATIBILITY AND EFFECTIVENESS | Beiersdorf AG (DE) | 2026-03-04 | — | — | EP | claimed |
| EP-4674894-A2 | COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES | Hemoteq AG (DE) | 2026-01-07 | — | — | EP | claimed |
| EP-3635363-B1 | METHODS FOR LARGE TISSUE LABELING, CLEARING AND IMAGING | DEEP PICTION GMBH (DE) | 2025-12-24 | — | — | EP | claimed |
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| EP-4663688-A2 | CROSSLINKERS | Hemoteq AG (DE) | 2025-12-17 | — | — | EP | claimed |
| EP-4658228-A1 | ECO-BIOLOGICAL COSMETIC COMPOSITION SUITABLE FOR REDUCING THE SIGNS OF CUTANEOUS AGEING | Thorel, Jean-Noël (FR) | 2025-12-10 | — | — | EP | claimed |
| US-12492973-B2 | Methods for large tissue labeling, clearing and imaging | DEEP PICTION GMBH (DE) | 2025-12-09 | — | — | US | claimed |
| EP-0786999-A1 | COMBINATION METHOD FOR ACNE TREATMENT | Merck & Co., Inc. (US) | 1997-08-06 | — | — | EP | claimed |
| WO-1997009973-A2 | PERIPHERALLY ACTIVE ANTI-HYPERALGESIC OPIATES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-03-20 | — | — | WO | claimed |
| US-5543417-A | 5 Alpha-reductase inhibitor and at least one of an antibacterial agent, a keratolytic agent or an anti-inflammatory agent | MERCK & CO., INC. (US) | 1996-08-06 | — | — | US | claimed |
| WO-1996018370-A1 | PROCESS FOR ENCAPSULATION OF CAPLETS IN A CAPSULE AND SOLID DOSAGE FORMS OBTAINABLE BY SUCH PROCESS | WARNER-LAMBERT COMPANY (US) | 1996-06-20 | — | — | WO | claimed |
| WO-1996012487-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1996012817-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| EP-0422765-A1 | Cosmetic composition | UNILEVER PLC (GB) | 1991-04-17 | — | — | EP | claimed |
| EP-0415598-A1 | Cosmetic composition | UNILEVER PLC (GB) | 1991-03-06 | — | — | EP | claimed |
| US-4876688-A | CONTAINING A CHIRAL CARBON | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECETARY OF THE DEPARTMENT OF ENERGY (US) | 1989-10-24 | — | — | US | claimed |
| US-3932638-A | Compositions and methods for wound healing | FRANCO-CHIMIE S.A.R.L. (FR) | 1976-01-13 | — | — | US | claimed |